22/564 Evaluating the Efficacy of Metformin in Tuberous Sclerosis Complex
The Efficacy and Mechanism Evaluation (EME) Programme is accepting stage 1 applications to their commissioned workstream.
- Closes: 13:00 on 25 April 2023
The Efficacy and Mechanism Evaluation (EME) Programme is accepting stage 1 applications to their commissioned workstream.
The EME Programme invites applications for Palliative and End of Life Care research.
The Efficacy and Mechanism Evaluation (EME) Programme is accepting stage 1 applications to their commissioned workstream.
The Efficacy and Mechanism Evaluation (EME) Programme is accepting stage 1 applications to their commissioned workstream.
The Efficacy and Mechanism Evaluation (EME) Programme is accepting stage one applications to their commissioned workstream